ArticleCancer research2019
CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC.
Jeffrey H Becker et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
40 papers cite it
this papercites it
ArticleCancer research2019
Jeffrey H Becker et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.